T
Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
Price:
21.41
CNY
-0.42%
Market Closed
Market Cap:
¥5.5B
Relative Value
The Relative Value of one Tianjin Lisheng Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 21.41 CNY, Tianjin Lisheng Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tianjin Lisheng Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Tianjin Lisheng Pharmaceutical Co Ltd Competitors
Tianjin Lisheng Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
|
5.5B CNY | 4.2 | 14.3 | 49.6 | 49.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
961.6B USD | 14.8 | 46.6 | 31.4 | 33.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.7B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
296.3B CHF | 4.8 | 31.5 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
239.2B GBP | 5.5 | 31.8 | 17.5 | 24.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
245.7B CHF | 5.6 | 22.6 | 13.9 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.6B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.5 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.7B USD | 2.5 | 20 | 7.5 | 10 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
92.3B GBP | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
